From: Effect of lycopene against gastroesophageal reflux disease in experimental animals
S. No. | Treatment | IL-1β (pg/ml) | IL-6 (pg/ml) |
---|---|---|---|
Group-I | Sham control (Normal saline,3 ml/kg,p.o) | 758.98 ± 30.61*** | 17673.16 ± 196.4*** |
Group-II | Esophagitis control (Normal saline,3 ml/kg,p.o) | 2595.9 ± 210.93 | 43429.33 ± 868.9 |
Group-III | Lycopene (50 mg/kg,p.o) | 755.68 ± 82.67*** | 25878.2 ± 405.1*** |
Group-IV | Lycopene (100 mg/kg,p.o) | 788.86 ± 38.19*** | 22055.31 ± 779.86***c |
Group-V | Pantoprazole (30 mg/kg,p.o) | 612.98 ± 44.47*** | 15611.14 ± 411.82*** |